Adverse Event post radiotherapy
Showing 1 - 25 of >10,000
Esophageal Tumors, Adverse Drug Event Trial in Nanjing (dietary supplement, drug, radiation)
Recruiting
- Esophageal Neoplasms
- Adverse Drug Event
- Nutritional Support Team
- +3 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Mar 23, 2023
Transitions of Care, General Medicine, Discharge Checklist Trial in Boston (Pre-Discharge Checklist and Patient Safety
Completed
- Transitions of Care
- +3 more
- Pre-Discharge Checklist and Patient Safety Dashboard
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 31, 2022
Transitions of Care, Patient Portals, General Medicine Trial in Boston (Interactive Digital Health Tools)
Completed
- Transitions of Care
- +6 more
- Interactive Digital Health Tools
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 21, 2022
Chemo-induced Nausea and Vomiting, Adverse Event, Cervical Cancer Trial in Odense (Akynzeo, Dexamethasone)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- +2 more
-
Odense, DenmarkDepartment of Oncology, Odense University Hospital
Dec 12, 2021
Denmark, Germany and Sweden
Recruiting
- Adverse Drug Event
- NOCDURNA Cohort
- LUTS Cohort
-
Bremen, GermanyGerman health care register, BIPS (there may be other sites)
May 9, 2022
Adverse Drug Event, Adverse Drug Reactions, Anaphylactic Reaction Trial in China (Xueshuantong-Injection)
Recruiting
- Adverse Drug Event
- +3 more
-
Hengshui, Hebei, China
- +13 more
Jul 4, 2021
Adverse Drug Event Trial in Canada (Deprescribing opportunities)
Completed
- Adverse Drug Event
- Deprescribing opportunities
-
Calgary, Alberta, Canada
- +6 more
May 13, 2021
Sarcoma Trial in Chapel Hill (GRID therapy)
Not yet recruiting
- Sarcoma
- GRID therapy
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill, Department of Radia
Oct 5, 2023
Breviscapine Powder-Injection : a Registry Study
Suspended
- Adverse Drug Event
- +3 more
- Breviscapine Powder-Injection
-
Chongqing, Chongqing, China
- +14 more
Apr 6, 2021
Atrial Fibrillation Trial in Columbia (No AAD post Ablation.)
Completed
- Atrial Fibrillation
- No AAD post Ablation.
-
Columbia, South CarolinaPalmetto Health
Mar 15, 2021
Postoperative Pain Trial in Australia, New Zealand (SABER-Bupivacaine, SABER-Placebo)
Completed
- Postoperative Pain
- SABER-Bupivacaine
- SABER-Placebo
-
Westmead, New South Wales, Australia
- +8 more
May 7, 2021
Muscle Invasive Bladder Cancer, HER2 Expression, Radiotherapy Trial in Shanghai (Disitamab Vedotin and Toripalimab)
Recruiting
- Muscle Invasive Bladder Cancer
- +4 more
- Disitamab Vedotin and Toripalimab
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Jul 31, 2023
Head and Neck Squamous Cell Carcinoma Trial in Spain (Dostarlimab, Niraparib, cisplatin plus radiotherapy)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Dostarlimab
- +2 more
-
Badalona, Cataluña, Spain
- +4 more
Mar 13, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Cervical Carcinoma, Endometrial Carcinoma, Endometriosis Trial in Scottsdale, Jacksonville, Rochester (Quality-of-Life
Recruiting
- Cervical Carcinoma
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)
Not yet recruiting
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- FLASH RT
- Conventional RT
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023
Breast Cancer, Triple Negative Breast Tumors Trial in France (Nivolumab, Ipilimumab, Capecitabine)
Active, not recruiting
- Breast Cancer
- Triple Negative Breast Neoplasms
- Nivolumab
- +2 more
-
Angers, France
- +16 more
Jul 21, 2022
Prostate Cancer Trial in Taiyuan (SpaceOAR Hydrogel)
Recruiting
- Prostate Cancer
- SpaceOAR Hydrogel
-
Taiyuan, Shanxi, ChinaShanxi Cancer Hospital
Feb 9, 2023
Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)
Recruiting
- Extensive-stage Small-cell Lung Cancer
- Radiotherapy
- Chemotherapy
-
Sydney, New South Wales, Australia
- +6 more
Mar 21, 2023
Head Neck Cancer, Head and Neck Tumors, Xerostomia Trial in Granada (Energy density photobiomodulation (7.5), Sham )
Recruiting
- Head and Neck Cancer
- +2 more
- Energy density photobiomodulation (7.5)
- Sham placebo
-
Granada, SpainFaculty of Health Sciences
Nov 6, 2022
Breast Cancer Stage III Trial in Seoul (Whole breast / chest wall & regional lymph node irradiation, Internal mammary or
Recruiting
- Breast Cancer Stage III
- Whole breast / chest wall & regional lymph node irradiation
- Internal mammary or supraclavicular lymph node boost
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Cervical Cancer Trial (Curcumin, Palliative radiotherapy)
Not yet recruiting
- Cervical Cancer
- Curcumin
- Palliative radiotherapy
- (no location specified)
Jul 14, 2023
Diffuse Large B Cell Lymphoma Trial (Bridging Radiotherapy)
Recruiting
- Diffuse Large B Cell Lymphoma
- Bridging Radiotherapy
-
Leeds, United Kingdom
- +2 more
Dec 6, 2022
Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of
Recruiting
- Sarcoma,Soft Tissue
- Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
- +2 more
-
Bordeaux, France
- +4 more
Mar 28, 2022
Cancer Trial in Edmonton (MR guided radiotherapy)
Recruiting
- Cancer
- MR guided radiotherapy
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 18, 2023